JAMA - Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19

JAMA - Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19

JAMA NETWORK

This study provides clinical status of a cohort of patients 4 months after hospitalization for COVID-19, but further research is needed to understand longer-term outcomes.

ECDC - Introducing a coherent European framework for tuning COVID-19 response measures

ECDC - Introducing a coherent European framework for tuning COVID-19 response measures

European Centre for Disease Prevention and ControlThis document describes the development of a coherent, yet non-prescriptive framework for tuning COVID-19 response measures in the European Union and European Economic Area (EU/EEA). Its aim is to...
ECDC - Considerations on the use of self-tests for COVID-19 in the EU/EEA

ECDC - Considerations on the use of self-tests for COVID-19 in the EU/EEA

European Centre for Disease Prevention and ControlRapid antigen detection tests (RADTs) that can be used as self-tests to detect SARS-CoV-2 are becoming available in the European Union/European Economic Area (EU/EEA). These tests require...
ECDC - Guidance for COVID-19 quarantine and testing of travellers

ECDC - Guidance for COVID-19 quarantine and testing of travellers

European Centre for Disease Prevention and ControlTravel measures, such as quarantine and testing of travellers, are designed to reduce the likelihood of SARS-CoV2 transmission prior to, during, and after travel. This document summarises the...
JAMA - SARS-CoV-2 Vaccines

JAMA - SARS-CoV-2 Vaccines

JAMA NETWORKShortly after SARS-CoV emerged at the turn of the 21st century, the spike (S) protein (particularly in its prefusion [native] conformation) was identified as the immunodominant antigen of the virus. Evaluation of patients with...
JAMA - Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19A Systematic Review and Meta-analysis

JAMA - Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19A Systematic Review and Meta-analysis

JAMA NETWORKIn a meta-analysis of 4 peer-reviewed and published randomized clinical trials including 1060 patients with COVID-19 treated with convalescent plasma vs control, the risk ratio for mortality was 0.93 and after the addition of 6...
NEJM - BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

NEJM - BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

The New England Journal of MedicineAs mass vaccination campaigns against coronavirus disease 2019 (Covid-19) commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes across diverse populations in a noncontrolled...
JAMA - Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19

JAMA - Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19

JAMA NETWORKHow do the characteristics and outcomes of children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compare with severe coronavirus disease 2019 (COVID-19)?
CDC - Operating schools during COVID-19: CDC's Considerations

CDC - Operating schools during COVID-19: CDC's Considerations

Centre for Disease Prevention and ControlAs communities in the United States consider how to safely re-open K-12 school buildings for in-person learning and activities and keep them open, CDC offers updated considerations for mitigation...
ECDC - Detection and characterisation capability and capacity for SARS-CoV-2 variants within the EU/EEA

ECDC - Detection and characterisation capability and capacity for SARS-CoV-2 variants within the EU/EEA

European Centre for Disease Prevention and ControlECDC’s rapid risk assessment on the spread of new SARS-CoV-2 variants of concern in the EU/EEA, published on 21 January 2021, concludes that the risk associated with the introduction and community...
BMJ - Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study

BMJ - Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study

British Medical JournalOf 4297 patients admitted to hospital with covid-19, 3627 (84.4%) received prophylactic anticoagulation within 24 hours of admission. More than 99% (n=3600) of treated patients received subcutaneous heparin or enoxaparin....
ECDC - Risk assessment: SARS-CoV-2 - increased circulation of variants of concern and vaccine rollout in the EU/EEA, 14th update

ECDC - Risk assessment: SARS-CoV-2 - increased circulation of variants of concern and vaccine rollout in the EU/EEA, 14th update

European Centre for Disease Prevention and ControlSeveral EU/EEA countries have observed a decline in the overall incidence of SARS-CoV-2 in recent weeks, most probably due to the impact of tightened non-pharmaceutical interventions (NPIs). 
ECDC - Using face masks in the community: first update - Effectiveness in reducing transmission of COVID-19

ECDC - Using face masks in the community: first update - Effectiveness in reducing transmission of COVID-19

European Centre for Disease Prevention and ControlThe role of face masks in the control and prevention of COVID-19 remains an issue of debate. Prior to COVID-19, most studies assessing the effectiveness of face masks as a protective measure in...
ECDC - Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA

ECDC - Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA

European Centre for Disease Prevention and ControlOn 19 January 2021 the European Commission set out actions to step up the response against the COVID-19 pandemic and accelerate the rollout of vaccination campaigns across the EU, with the aim to...
ECDC - Integrated COVID-19 response in the vaccination era

ECDC - Integrated COVID-19 response in the vaccination era

European Centre for Disease Prevention and ControlDue to the emergence of more transmissible variants of SARS-CoV-2, it will be necessary to strengthen and maintain response measures in the coming months to avoid further rises in mortality, even...
135678910Último
Categorias

Categorias

Arquivo de Notícias

Arquivo